Neuroprotective effect of butin against rotenone-induced Parkinson’s disease mediated by antioxidant and anti-inflammatory actions through paraoxonase-1-induction

References

• Alyamani AM, Alarifi J, Alfadhel A, et al. Public knowledge and awareness about Parkinson’s disease in Saudi Arabia. J Family Med Prim Care. 2018;7(6):1216.
   PubMedGoogle Scholar
• Geibl FF, Henrich MT, Oertel WH. Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease. J Neural Transm. 2019;126(4):377–396.
   PubMed Web of Science ®Google Scholar
• Mbiydzenyuy NE, Ninsiima HI, Valladares MB, et al. Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism. BMC Neurosci. 2018;19(1):1–11.
   PubMedGoogle Scholar
• Hallett M. Tremor: pathophysiology. Parkinsonism Relat Disord. 2014;20:S118–SS22.
   PubMedGoogle Scholar
• Elbaz A, Tranchant C. Epidemiologic studies of environmental exposures in Parkinson’s disease. J Neurol Sci. 2007;262(1–2):37–44.
   PubMed Web of Science ®Google Scholar
• Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature Clinical Practice Neurology. 2008;4(11):600–609.
   PubMedGoogle Scholar
• Hwang O. Role of oxidative stress in Parkinson’s disease. Exp Neurobiol. 2013;22(1):11.
   PubMedGoogle Scholar
• Garabadu D, Agrawal N. Naringin exhibits neuroprotection against rotenone-induced neurotoxicity in experimental rodents. NeuroMol Med. 202022(2):314–330.
   PubMed Web of Science ®Google Scholar
• Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longevity. 2015;2015:1–18.
   Web of Science ®Google Scholar
• Hassanzadeh K, Rahimmi A. Oxidative stress and neuroinflammation in the story of Parkinson’s disease: could targeting these pathways write a good ending? J Cell Physiol. 2019;234(1):23–32.
   Web of Science ®Google Scholar
• Tian G, Zhang U, Zhang T, et al. Separation of flavonoids from the seeds of Vernonia anthelmintica Willd by high-speed counter-current chromatography. J Chromatogr, A. 2004;1049(1–2):219–222.
   PubMed Web of Science ®Google Scholar
• Liu R-X, Wang Q, Guo H-Z, et al. Simultaneous determination of 10 major flavonoids in Dalbergia odorifera by high performance liquid chromatography. J Pharm Biomed Anal. 2005;39(3-4):469–476.
   PubMed Web of Science ®Google Scholar
• Su E-N, Yu S-S, Pei Y-H. Studies on chemical constituents from stems and leaves of Adenanthera pavanina. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China Journal of Chinese materia medica. 2007;32(20):2135–2138.
   PubMedGoogle Scholar
• Zhang R, Chae S, Kang KA, et al. Protective effect of butin against hydrogen peroxide-induced apoptosis by scavenging reactive oxygen species and activating antioxidant enzymes. Mol Cell Biochem. 2008;318(1):33–42.
   PubMed Web of Science ®Google Scholar
• Kang KA, Lee JH, Chae S, et al. Butin decreases oxidative stress-induced 8-hydroxy-2′-deoxyguanosine levels via activation of oxoguanine glycosylase 1. Chem-Biol Interact. 2009;181(3):338–342.
   PubMed Web of Science ®Google Scholar
• Zhang R, Kang KA, Piao MJ, et al. Butin reduces oxidative stress-induced mitochondrial dysfunction via scavenging of reactive oxygen species. Food Chem Toxicol. 2010;48(3):922–927.
   PubMed Web of Science ®Google Scholar
• Zhang R, Lee IK, Piao MJ, et al. Butin (7,3′,4′-trihydroxydihydroflavone) reduces oxidative stress-induced cell death via inhibition of the mitochondria-dependent apoptotic pathway. Int J Mol Sci. 2011;12(6):3871–3887.
   PubMed Web of Science ®Google Scholar
• Alshehri S, Al-Abbasi FA, Ghoneim MM, et al. Anti-Huntington’s effect of butin in 3-nitropropionic acid-treated rats: possible mechanism of action. Neurotox Res. 2022;40(1):66–77.
   PubMed Web of Science ®Google Scholar
• Alzarea SI, Alasmari AF, Alanazi AS, et al. Butin attenuates arthritis in complete Freund’s adjuvant-treated arthritic rats: possibly mediated by its antioxidant and anti-inflammatory actions. Front Pharmacol. 2022;13:810052.
   PubMed Web of Science ®Google Scholar
• Sharma N, Bafna P. Effect of Cynodon dactylon on rotenone induced Parkinson’s disease. Orient Pharm Exp Med. 2012;12(3):167–175.
   Google Scholar
• Venkateshgobi V, Rajasankar S, Johnson W, et al. Neuroprotective effect of Agaricus blazei extract against rotenone-induced motor and nonmotor symptoms in experimental model of Parkinson’s disease. Int J Nutr, Pharmacol, Neurol Dis. 2018;8(2):59–65.
   Google Scholar
• Kumar P, Kumar A. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington’s disease like symptoms: possible behavioural, biochemical and cellular alterations. Eur J Pharmacol. 2009;615(1–3):91–101.
   PubMed Web of Science ®Google Scholar
• Dhadde SB, Nagakannan P, Roopesh M, et al. Effect of embelin against 3-nitropropionic acid-induced Huntington’s disease in rats. Biomed Pharmacother. 2016;77:52–58.
   PubMed Web of Science ®Google Scholar
• Shaikh A, Dhadde SB, Durg S, et al. Effect of Embelin against lipopolysaccharide-induced sickness behaviour in mice. Phytother Res. 2016;30(5):815–822.
   PubMed Web of Science ®Google Scholar
• Durg S BNK, Vandal R, Dhadde SB, et al. Antipsychotic activity of embelin isolated from Embelia ribes: a preliminary study. Biomed Pharmacother. 2017;90:328–331.
   PubMed Web of Science ®Google Scholar
• Dhadde SB, Durg S, Potadar PP, et al. Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice. Toxicol Mech Methods. 2014;24(9):672–678.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88–95.
   PubMed Web of Science ®Google Scholar
• Wysocka A, Cybulski M, Berbeć H, et al. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery. BMC Cardiovasc Disord. 2017;17(1):92-.
   PubMedGoogle Scholar
• Abdel-Salam OME, Youness ER, Khadrawy YA, et al. Acetylcholinesterase, butyrylcholinesterase and paraoxonase 1 activities in rats treated with cannabis, tramadol or both. Asian Pac J Trop Med. 2016;9(11):1089–1094.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77.
   PubMed Web of Science ®Google Scholar
• Aebi H, Wyss SR, Scherz B, et al. Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits. Eur J Biochem. 1974;48(1):137–145.
   PubMedGoogle Scholar
• Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170–3175.
   PubMed Web of Science ®Google Scholar
• Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochem J. 1966;99(3):667–676.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126(1):131–138.
   PubMed Web of Science ®Google Scholar
• Nagakannan P, Shivasharan BD, Thippeswamy BS, et al. Restoration of brain antioxidant status by hydroalcoholic extract of Mimusops elengi flowers in rats treated with monosodium glutamate. J Environ Pathol Toxicol Oncol. 2012;31(3):213–221.
   PubMed Web of Science ®Google Scholar
• Lawana V, Cannon JR. Chapter five – rotenone neurotoxicity: relevance to Parkinson’s disease. In: Aschner M, Costa LG, editor. Advances in neurotoxicology. 4. Cambridge (MA): Academic Press; 2020. p. 209–254.
   Google Scholar
• Klein MO, Battagello DS, Cardoso AR, et al. Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol. 2019;39(1):31–59.
   PubMed Web of Science ®Google Scholar
• Liu C, Kaeser PS. Mechanisms and regulation of dopamine release. Curr Opin Neurobiol. 2019;57:46–53.
   PubMed Web of Science ®Google Scholar
• Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13(12):409-.
   PubMed Web of Science ®Google Scholar
• Binawade Y, Jagtap A. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington’s disease-like symptoms: possible behavioral, biochemical, and cellular alterations. J Med Food. 2013;16(10):934–943.
   PubMed Web of Science ®Google Scholar
• Caggiu E, Arru G, Hosseini S, et al. Inflammation, infectious triggers, and Parkinson’s disease. Front Neurol. 2019;10:122.
   PubMed Web of Science ®Google Scholar
• Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012;4(11):523–532.
   PubMedGoogle Scholar
• Shunmoogam N, Naidoo P, Chilton R. Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance. Vasc Health Risk Manag. 2018;14:137–143.
   PubMed Web of Science ®Google Scholar